Resmetirom reduces lipid load, restores THRB expression and prevents cell damage in a human stem cell based in vitro MAFLD model.

Gatzios, A. (Speaker), Marcelino Rodrigues, R. (Contributor), De Kock, J. (Contributor), Verhoeven, A. (Contributor), Sepehri, S. (Contributor), Buyl, K. (Contributor), Rombaut, M. (Contributor), Rogiers, V. (Contributor), Boeckmans, J. (Contributor), Vanhaecke, T. (Contributor)

Activiteit: Talk or presentation at a conference

Periode10 jun 2022
Evenementstitel3rd European Fatty Liver Conference
EvenementstypeConference
LocatieMaastricht, Netherlands
Mate van erkenningInternational